Navigation Links
Walking tall to protect the species
Date:12/12/2007

The transition from apes to humans may have been partially triggered by the need to stand on two legs, in order to safely carry heavier babies. This theory1 of species evolution presented by Lia Amaral from the University of So Paulo in Brazil has just been published online in Springers journal, Naturwissenschaften.

For safety, all nonhuman primates carry their young clinging to their fur from birth, and species survival depends on it. The carrying pattern changes as the infant grows. Newborns are carried clinging to their mothers stomach, often with additional support. Months later, infants are carried over the adult body usually on the mothers back, and this carrying pattern lasts for years in apes. However, this necessity to carry infants safely imposes limits on the weight of the infants.

Through a detailed mechanical analysis of how different types of apes - gibbons, orangutans and gorillas - carry their young, looking at the properties of ape hair, infant grip, adult hair density and carrying position, Amaral demonstrates a relationship between infant weight, hair friction and body angle which ensures ape infants are carried safely.

Amaral also shows how the usual pattern of primate carrying of heavy infants is incompatible with bipedalism. African apes have to persist with knuckle-walking on all fours, or quadruped position, in order to stop their young from slipping off their backs.

The author goes on to suggest that the fall in body hair in primates could have brought on bipedality as a necessary consequence, through the strong selective pressure of safe infant carrying, as infants were no longer able to cling to their mothers body hairs. In the authors opinion, safe carrying of heavy infants justified the emergence of the biped form of movement. Although an adult gorilla is much heavier than an adult human, its offspring is only half the weight of a human baby.

Amaral concludes that this evolution to b
'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert

Page: 1 2

Related biology news :

1. Rain forest protection works in Peru
2. Same gene protects from 1 disease, opens door to another
3. Conservation International and Toyota partner to protect Philippines rain forests
4. Fungus genome yielding answers to protect grains, people and animals
5. Genes that both extend life and protect against cancer identified
6. Intravenous gene therapy protects normal tissue of mice during whole-body radiation
7. Rosemary chicken protects your brain from free radicals
8. Genes identified to protect brassicas from damaging disease
9. Antioxidants could provide all-purpose radiation protection
10. Secure Services Corp. Achieves Milestone in United States Identity Protection with the Launch of the SSC SHAPE Card Management Solution
11. Omega-3 fatty acids protect against Parkinsons, study says

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... , Sewer overflows are a nasty business, posing d...Carolina State University is launching a new proje...tion Agency (EPA) that targets the fat and grease ...r, and will give urban planners new tools to furth...are overflows from "sanitary" sewer systems, as op...
(Date:11/22/2009)... , CINCINNATI -- Children exposed prenatally to t...articularly high risk for ADHD, according to resea... Center. , The study estimates that up to 35 per... 8 and 15 could be reduced by eliminating both of ...e into up to 800,000 children , "Tobacco and le...
(Date:11/22/2009)... , A commonly inherited gene deletion can increas... bone marrow transplantation, an international tea...e online issue of Nature Genetics . When the gene...me but present in the recipient,s, transplants hav...ffect known as graft-versus-host disease, in which...
Breaking Biology News(10 mins):Lose the fat: Targeting grease to curtail sewer overflows 2Exposure to lead, tobacco smoke raises risk of ADHD 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis 4678 1BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis 4678 2Reverse Ages Staying Young Naturally 50696 1ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 1ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 2ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 3ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 4ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB 402 4677 5
...ctors from different hospitals can collaborate on ...rating room. What if doctors in remote locations c...cialists in hospitals around the world? , This en...search by a multi-university partnership that is t...dvanced networking consortium Internet2. , Roche...
...g is causing the worldwide declines of amphibians ...cording to biologists. The findings, which contrad...is killing the frogs and toads and aid in their co... sixth mass extinction event," said Peter Hudson, ...d co-author of the research study. "And amphibians...
...matodes are extreme parasites. These microscopic, ...ral and field crops in sub-tropical regions, resul...d gardeners. , Until recently, fumigation of the ...rimary method for controlling root-knot nematodes ... is an odorless, colorless gas that has been widel...
Other Biology News:The next step in health care: Telemedicine 2Global warming link to amphibian declines in doubt 2Global warming link to amphibian declines in doubt 3Parasite-resistant peppers green alternatives to chemical pesticides 2
(Date:11/23/2009)...Nov.23/PRNewswire/--PearlTherapeuticsInc.,abiophar...hetreatmentofchronicrespiratorydiseases,todayannou...fDirectors.Mr.Rosenhas25yearsofexperienceinthephar...olesatGileadSciencesandALZACorporation.Hisappointm...x. ,, "Howiebringsawealthofproductdevelopment,c...
(Date:11/20/2009)...0 Dendreon Corporation (... and Drug Administration (FDA) provided written ac... License Application (BLA) for PROVENGE® (sip...signed a Prescription Drug User Fee Act (PDUFA) da...o Dendreon,s amended BLA. Dendreon is seeking lic...
(Date:11/20/2009)...ETTLER TOLEDO recently announced that Dr. Dominiqu... Role of Process Analytical Technology (PAT) in Gr...mber 1, 2009. , (PRWEB) N...s Analytical Technology (PAT) in Green Chemistry a...ss Analytical Technology (PAT) case studies will b...
(Date:11/19/2009)...ESDA, Md., Nov. 19 Spher...biotechnology for diabetes therapy, and a provider...o food, supplement, biotechnology and pharmaceutic...usly reported $6.3 million registered direct place...s of its common stock and warrants to purchase up ...
Breaking Biology Technology:Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3
...ent, BASEL, Switzerland and TUCSON, Ariz., Jan. 2...d-leading healthcare,provider of pharmaceuticals a...ana") (Nasdaq: VMSI ) today announced that they h...e terms of the agreement, Roche will,increase the ...mon shares,to $89.50 per share in cash (or an aggr...
...x,Orthobiology B.V. announced today the closure of...y BioGeneration Ventures., Progentix Orthobiology...e suite of osteoinductive material products for cl...rogentix bone graft material is based on,surface s...the ability to,attract growth factors and stems ce...
...s,announced that it will continue to provide Avast...thalmologists who request it for their patients.,T..., Genentech,s, decision,( http://www.lucentis.com/...Avastin directly to compounding pharmacies as of J...tinal specialists and,ophthalmologists to treat ag...
Other Biology Technology:Roche to Acquire Ventana for $89.50 per share 2Roche to Acquire Ventana for $89.50 per share 3Roche to Acquire Ventana for $89.50 per share 4Roche to Acquire Ventana for $89.50 per share 5Roche to Acquire Ventana for $89.50 per share 6Progentix Orthobiology B.V. Closes Series A Financing Round 2Wedgewood Pharmacy Will Continue to Provide Avastin(R) to Ophthalmologists and Retinal Specialists 2Wedgewood Pharmacy Will Continue to Provide Avastin(R) to Ophthalmologists and Retinal Specialists 3
Eosinophil Chip-IHC from 3H Biomedical AB
B Cell Chip-IHC from 3H Biomedical AB
Basophil Chip-IHC from 3H Biomedical AB
UCB CD4 T Cell Chip-IHC from 3H Biomedical AB
Biology Products: